title: Radiolabelled porphyrins in nuclear medicine.
abstract: Amongst tumour-specific substances, hematoporphyrin and synthetic porphyrin derivatives have been widely investigated to identify and delineate neoplastic and malignant tissue. Whilst the tumour localization exhibited by selected porphyrin species has been exploited through photodynamic therapy, several examples of porphyrin derivatives with varied peripheral functionality have been radiolabelled with the aim of developing porphyrin-based nuclear imaging and therapeutic agents. In this review, we look at the approaches and advances in the preparation and uses of such radiolabelled agents for imaging and therapy.
authors.affiliation: CR-UK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford, OX3 7LE, UK; Chemistry Research Laboratory, University of Oxford, 12 Mansfield Road, Oxford, OX1 3TA, UK.
authors.forename: Philip A
authors.initials: PA
authors.lastname: Waghorn
mesh_terms: D000818:Animals; D002614:Chelating Agents / Q000737:chemistry; D006801:Humans; D007553:Isotope Labeling; D053758:Nanoparticles / Q000737:chemistry; D009683:Nuclear Medicine / Q000379:methods*; D011166:Porphyrins / Q000737:chemistry* / Q000627:therapeutic use
chemical_list: D002614:Chelating Agents; D011166:Porphyrins
keywords: PET; SPECT; fluorescence; imaging; porphyrins; therapy